{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-072288","form_type":"8-K","ticker":"SMNR","cik":"0001913577","company_name":"Semnur Pharmaceuticals, Inc.","filed_at":"2023-08-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.060575+00:00","generated_at":"2026-06-11T02:07:44.665861+00:00","sec_items":["8.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Longevity Biomedical waives $30M minimum cash condition for Denali merger","bullets":["Longevity irrevocably waived the $30M minimum cash condition in the merger agreement with Denali Capital Acquisition Corp.","Waiver effective August 29, 2023; removes a key closing condition for the business combination.","Merger agreement originally signed Jan 25, 2023, amended April 11, 2023.","Parties include Denali, Longevity, Holdco, Merger Subs, and seller representative Bradford A. Zakes."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-072288","json":"https://secwatch.observer/filing/0001213900-23-072288.json","markdown":"https://secwatch.observer/filing/0001213900-23-072288.md","text":"https://secwatch.observer/filing/0001213900-23-072288.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1913577/000121390023072288/0001213900-23-072288-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1913577/000121390023072288/ea184480-8k425_denalicap.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T02:07:44.665861+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}